$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research
08:30am, Wednesday, 15'th Jan 2025
New, Fully Automated, High-Throughput RUO Assays offered on Beckman Coulter Immunoassay Analyzers BREA, Calif. , Jan. 15, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in advance
Danaher Corporation (DHR) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)
05:44pm, Tuesday, 14'th Jan 2025
Danaher Corporation (NYSE:DHR ) 43rd Annual J.P. Morgan Healthcare Conference January 14, 2024 2:15 PM ET Company Participants Rainer Blair - President and Chief Executive Officer Conference Call Part
Danaher CEO to Comment on Financial Performance
04:15pm, Monday, 13'th Jan 2025
WASHINGTON , Jan. 13, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Compa
Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth
12:07pm, Monday, 13'th Jan 2025
Seeking Alpha's Quant Valuation and Growth Grades identify 6 blue-chip stocks with extremely high valuations matched against limited operating growth potential. Costco, Cencora, West Pharmaceutical Se
Danaher Announces Investment Partnership in Innovaccer Inc.
04:15pm, Thursday, 09'th Jan 2025
Partnership seeks to improve patient outcomes and experience through novel digital and diagnostic solutions. Investment aligns with Danaher's mission to accelerate the transition to precision medicine
Danaher to Present at J.P. Morgan Healthcare Conference
04:15pm, Monday, 06'th Jan 2025
WASHINGTON , Jan. 6, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P.
Danaher: A Wide-Moat Gem I Cannot Buy Enough Of
09:00am, Monday, 06'th Jan 2025
Danaher boasts a wide-moat business model with mission-critical products and recurring revenue streams, ensuring a durable competitive advantage and long-term growth potential. The company's disciplin
Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report?
01:16pm, Friday, 03'rd Jan 2025
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Danaher Schedules Fourth Quarter 2024 Earnings Conference Call
04:05pm, Thursday, 02'nd Jan 2025
WASHINGTON , Jan. 2, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2024 on Wednesday, January 29, 20
3 of the Best Companies to Own in 2025 and Beyond
11:20am, Tuesday, 17'th Dec 2024
#Morningstar #BestStockstoInvestIn #StockInvesting These companies have durable competitive advantages and generate reliable cash flows. 00:00 Introduction 00:46 Danaher DHR 01:36 Paychex PAYX 02:1
Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value
11:54pm, Friday, 13'th Dec 2024
Concentrate on a select few high-conviction stocks across different sectors to avoid "diworsification" and maximize returns, inspired by Charlie Munger and Warren Buffett. Utilize Joel Greenblatt's "M
Danaher Announces Quarterly Dividend
04:15pm, Tuesday, 10'th Dec 2024
WASHINGTON , Dec. 10, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common
Here's Why You Should Avoid Investing in Danaher Stock Right Now
11:15am, Tuesday, 10'th Dec 2024
DHR experiences weakness in its operations due to softness in the Life Sciences segment. Rising expenses are added concerns.
Danaher: A Resilient And Solid Company With Growth Potential
05:30am, Tuesday, 10'th Dec 2024
Danaher has maintained a net earning margin above 15% since 2017. In 2024 Q3, the company had a 36.36% liabilities-to-assets ratio, the lowest level since 2017. Danaher's largest customers have reduce
Danaher Corporation (DHR) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
08:02am, Thursday, 05'th Dec 2024
Danaher Corporation (NYSE:DHR ) Annual Evercore ISI HealthCONx Healthcare Conference December 4, 2024 3:25 PM ET Company Participants Rainer Blair - President and CEO Conference Call Participants Vija
Sign In
Buy DHR